Tricor and Ejection fraction decreased - a phase IV clinical study of FDA data

Summary:

Ejection fraction decreased is reported as a side effect among people who take Tricor (fenofibrate), especially for people who are 60+ old, have been taking the drug for 1 - 2 years also take Digoxin, and have Arrhythmias.

The phase IV clinical study analyzes which people have Ejection fraction decreased when taking Tricor. It is created by eHealthMe based on reports of 21,730 people who have side effects when taking Tricor from the FDA, and is updated regularly.

What is Tricor?

Tricor has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 22,641 Tricor users. Check the latest studies of Tricor.

What is Ejection fraction decreased?

Ejection fraction decreased (systolic heart failure) is found to be associated with 1,063 drugs and 1,255 conditions by eHealthMe. Check the latest studies of Ejection fraction decreased.

On Jul, 24, 2026

21,730 people reported to have side effects when taking Tricor.
Among them, 54 people (0.25%) have Ejection fraction decreased.

$Could Tricor cause Ejection fraction decreased?$

Among these 54 people:

How long have people been on Tricor when they have Ejection fraction decreased? *

What is the age of people who have Ejection fraction decreased when taking Tricor? *

What are other drugs people take besides Tricor? *

What are other side effects people have besides Ejection fraction decreased? *

Cardiac Failure Congestive: 21 people, 38.89%
Dyspnea (difficult or laboured breathing): 19 people, 35.19%
Mitral Valve Incompetence (inefficient heart valve): 18 people, 33.33%
Chest Pain: 17 people, 31.48%
Tricuspid Valve Incompetence (inefficient heart valve): 16 people, 29.63%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 15 people, 27.78%
Acute Kidney Failure: 15 people, 27.78%
Headache (pain in head): 15 people, 27.78%
Heart Attack: 15 people, 27.78%
Cardiomyopathy (weakening of the heart muscle): 13 people, 24.07%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 5.56%
Arrhythmias (irregular heartbeat): 3 people, 5.56%
Type 2 Diabetes: 2 people, 3.70%
Multiple Myeloma (cancer of the plasma cells): 2 people, 3.70%
Depression: 2 people, 3.70%
Cardiac Failure Congestive: 2 people, 3.70%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 3.70%
Anaemia (lack of blood): 2 people, 3.70%
Stress And Anxiety: 2 people, 3.70%
Blood Disorder: 1 person, 1.85%

* Approximation only. Some reports may have incomplete information.

Do you take Tricor and have Ejection fraction decreased?

- Check whether Ejection fraction decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tricor:

Tricor (22,641 reports)

Browse all side effects of Tricor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ejection fraction decreased:

Ejection fraction decreased (1,063 drugs)

Browse all the conditions that are associated with Ejection fraction decreased:

Ejection fraction decreased (1,255 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Tricor) and Tricor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.